1-5 of 5
James A. Reeves, MD
Close
Sort by
Journal Articles

Umbralisib, the Once Daily Dual Inhibitor of PI3Kδ and Casein Kinase-1ε Demonstrates Clinical Activity in Patients with Relapsed or Refractory Indolent Non-Hodgkin Lymphoma: Results from the Phase 2 Global Unity-NHL Trial

Pier Luigi Zinzani, MD, Felipe Samaniego, MD, Wojciech Jurczak, MD PhD, Nilanjan Ghosh, MD PhD, Enrico Derenzini, MD PhD, James A Reeves, MD, Wanda Knopinska-Posluszny, MD PhD, Chan Yoon Cheah, MBBS, Tycel J. Phillips, MD, Ewa Lech-Marańda, MD PhD, Bruce D. Cheson, MD, Paolo F Caimi, MD, Sebastian Grosicki, MD PhD, Lori A. Leslie, MD, Julio C. Chavez, MD, Gustavo A. Fonseca, MD, Sunil Babu, Daniel J. Hodson, MDPhD, Spencer H. Shao, MD, John M. Burke, MD, Jeff P Sharman, MD, Jennie Y. Law, MD, John M. Pagel, MDPhD, Owen A. O'Connor, MD PhD, Hari P. Miskin, MSc, Peter Sportelli, BS, Michael S. Weiss, Nathan H Fowler, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 34–35.
https://doi.org/10.1182/blood-2020-134851
Published: 2020
Journal Articles

Randomized Phase 2 Open-Label Study of R-CHOP ± Bortezomib in Patients (Pts) with Untreated Non-Germinal Center B-Cell-like (Non-GCB) Subtype Diffuse Large Cell Lymphoma (DLBCL): Results from the Pyramid Trial (NCT00931918)

John P. Leonard, MD, Kathryn Kolibaba, MD, James A. Reeves, MD, Anil Tulpule, MD, Ian W. Flinn, MD PhD, Tatjana Kolevska, MD, Robert Robles, MD, Christopher Flowers, MD, Robert Collins, MD, Nicholas J. DiBella, MD, Steven W. Papish, MD, Parameswaran Venugopal, MD, Andrew Horodner, MD, Amir Tabatabai, MD, Julio Hajdenberg, MD, George Mulligan, PhD, Rachel Neuwirth, PhD, Kaveri Suryanarayan, Dixie-Lee Esseltine, MD, Sven de Vos, MD PhD
Journal: Blood
Blood (2015) 126 (23): 811.
https://doi.org/10.1182/blood.V126.23.811.811
Published: 2015
Journal Articles

Rapid Prospective Identification of Non-Germinal Center B Cell-Like (GCB) Diffuse Large B-Cell Lymphoma (DLBCL) Patients for Targeted Trials: Early Results From PYRAMID, A Phase 2 Randomized Study of R-CHOP ± Bortezomib In Newly Diagnosed Non-GCB DLBCL.

Kevin Doner, MD, Ian W. Flinn, MD, PhD, Brian K. Ulrich, MD, Stephen J. Noga, MD, PhD, Naveed M. Chowhan, MD, Steven W. Papish, MD, Tallat Mahmood, MD, James A Reeves, MD, Nicholas J. Di Bella, MD, Gerald J. Robbins, MD, Radhakrishnan Ramchandren, MD, Sein Aung, MD, William Lawler, MD, Sudha Parasuraman, MD, Maria M. Corvez, BA, George Mulligan, PhD, John P. Leonard, MD
Journal: Blood
Blood (2010) 116 (21): 1792.
https://doi.org/10.1182/blood.V116.21.1792.1792
Published: 2010
Journal Articles

Phase 3b UPFRONT Study: Safety and Efficacy of Weekly Bortezomib Maintenance Therapy After Bortezomib-Based Induction Regimens In Elderly, Newly Diagnosed Multiple Myeloma Patients

Ruben Niesvizky, MD, Ian W. Flinn, MD, PhD, Robert M. Rifkin, MD, Nashat Y Gabrail, MD, Veena Charu, MD, Billy Clowney, MD, James Essell, MD, Yousuf A Gaffar, MD, Thomas A. Warr, MD, Rachel Neuwirth, MS, Deyanira Corzo, MD, James A Reeves, MD
Journal: Blood
Blood (2010) 116 (21): 619.
https://doi.org/10.1182/blood.V116.21.619.619
Published: 2010
Journal Articles

Patient-Reported Quality of Life In Elderly, Newly Diagnosed Multiple Myeloma Patients Treated with Bortezomib-Based Regimens: Results From the Phase 3b UPFRONT Study

Ruben Niesvizky, MD, Ian W. Flinn, MD, PhD, Robert M. Rifkin, MD, Nashat Y Gabrail, MD, Veena Charu, MD, Billy Clowney, MD, James Essell, MD, Yousuf A Gaffar, MD, Thomas A. Warr, MD, Rachel Neuwirth, MS, Deyanira Corzo, MD, James A Reeves, MD
Journal: Blood
Blood (2010) 116 (21): 3026.
https://doi.org/10.1182/blood.V116.21.3026.3026
Published: 2010